QNRX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep quoinpharma.com

Logo korporat perusahaan Quoin Pharma (QNRX)

The projected EPS growth rate for next year complements data regarding Quoin Pharmaceuticals (QNRX) partnerships with global distributors to accelerate the launch of dermatological gels. Meanwhile, the value of 52.90 serves as a baseline metric for the strategy to capture the Netherton syndrome therapy niche, although resource shortages and a limited patient pool for testing create risks of regular capital dilution.

QNRX - Prakiraan wutah bathi kanggo taun ngarep Quoin Pharma ing rentang 04.07.2022 - 17.11.2026

QNRX (Quoin Pharma): rincian analitis lan laporan miturut indikator

Analisis umum perusahaan:Quoin Pharmaceuticals Ltd
Produk dadi Quoin Pharmaceuticals Ltd

The specific nature of Quoin Pharmaceuticals (QNRX), characterized by its dependence on orphan drug clinical trial outcomes and a high burn rate, makes shifts in analyst expectations for n+1 EPS growth a critical indicator of viability. By synthesizing the order book microstructure, this metric assesses the consensus profit forecast for the coming year, allowing investors to differentiate the actual monetization potential of developments from the speculative risk of missed opportunities.

Analisis pesaing Quoin Pharmaceuticals

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Krystal Biotech|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep APGE (Apogee Therapeutics)|Prakiraan wutah bathi kanggo taun ngarep ARQT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep VCEL (Vericel)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Oruka Corp ORKA|Prakiraan wutah bathi kanggo taun ngarep Sanara MedTech Inc. SMTI|DBVT: Prakiraan wutah bathi saben saham kanggo taun ngarep|SLSN: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Journey Medical Corp. (DERM) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|FBRX: Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep empro.my|SLGL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep AXIL|Prakiraan wutah bathi kanggo taun ngarep medicuspharma.com (MDCX)|Prakiraan wutah bathi kanggo taun ngarep VRCA (Verrica Pharmaceuticals Inc)|Dinamika bathi saben saham sing diarepake ing taun ngarep HOTH|BFRI: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep VYNE Therapeutics Inc.|SNOA: Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AZTR|DRMA (Dermata Therapeutics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ELAB|Prakiraan wutah bathi kanggo taun ngarep RVNC